VIASURE Viral Particles
VIASURE Viral SARS-CoV-2 Positive Control Kit
VIASURE Viral SARS-CoV-2 Positive Control Kit is based on RNA particles from SARS-CoV-2 virus.
This control is intended for monitoring the whole process, from nucleic acid extraction to amplification with all nucleic acid detection assays designed for amplification of authorized WHO RT-qPCR protocols.
Description
VIASURE Viral SARS-CoV-2 Positive Control Kit is intended for monitoring the whole reverse transcription quantitative real-time PCR (RT-qPCR) process, from nucleic acid extraction to reverse transcription and amplification steps.
VIASURE Viral SARS-CoV-2 Positive Control Kit contains non-replicative and non-infectious SARS-CoV-2 viral particles that are expected to be processed along with respiratory samples from individuals with clinical suspicion of COVID-19. These viral particles are designed to be compatible with the following WHO RT-qPCR protocols: China CDC (China), US CDC (USA), National Institute of Infectious Diseases (Japan), Charité (Germany), HKU (Hong Kong SAR) and National Institute of Health (Thailand).
This Kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in molecular techniques and in vitro diagnostic procedures.
Specifications
Inactivated viral particles. Non infectious & Non replicatives.
Lyophilized presentation: transport and store at room temperature with a shelf life of 24 months.
Monodose format for nucleic acid detection techniques.
Final concentration range quantified by digital PCR: 11.000-110.000 copies per vial.
Compatible with most common RNA extraction methods and WHO RT-qPCR protocols: China CDC, US CDC (USA), National Institute of Infectious Diseases (Japan), Charité (Germany), HKU (Hong Kong SAR) and National Institute of Health (Thailand).
